Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...
Vaccinations prevent 4–5 million deaths annually, according to WHO. Immunization coverage for diseases like measles and diphtheria exceeds 85%, reducing global mortality rates significantly and ...